查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1402024

到 2030 年辅助生殖技术的市场预测：按产品、程序、技术、最终用户和地区进行的全球分析

Assisted Reproductive Technology Market Forecasts to 2030 - Global Analysis By Product, Procedure, Technology, End User and by Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2023 年全球辅助生殖技术市场规模为 290.1 亿美元，预测期内复合年增长率为 10.4%，到 2030 年将达到 579.9 亿美元。

辅助生殖技术是指在传统方法不成功的情况下旨在帮助个人和夫妇怀孕的各种医疗程序。子宫内人工授精 (IUI)、体外受精 (IVF) 和生育药物都属于这个通用术语。 ART 也大大改变了生殖医学，为那些饱受不孕和怀孕困扰的人们带来了希望。

根据国立食品科学研究所2022年12月发布的女性不孕资料显示，过去生产过活产的女性中，有11%将无法再次生下活产，而全球整体要到20岁才能再生产一个活产婴儿。据说，44岁至44岁的女性中有2%根本无法生产活产婴儿。

不孕率上升

不孕率不断上升，其原因很大程度上与以高压力、久坐行为和环境变数为特征的现代生活方式有关。此外，子宫内膜异位症和卵巢症候群（PCOS）等疾病也会显着增加不孕症的发生率。随着越来越多的人和夫妇难以自然受孕，对辅助生殖技术的需求不断增加，这凸显了这些干预措施作为治疗方法不孕症的必要性。

成功率有限

儘管由于技术进步，ART，尤其是IVF的成功率有所提高，但妊娠并不能保证。此外，对治疗、年龄和基础医疗状况反应的个体差异可能会限制这些干预措施的有效性。对于那些考虑 ART 的人来说，固有的不确定性和可变的成功率仍然是主要的阻碍力。

扩大冷冻保存的用途

卵子、精子和胚胎等生殖材料可以透过玻璃化等冷冻保存技术延长存活时间。此外，这可以更好地与人们的生活决策和环境同步。保存生育能力以供日后使用的能力扩大了冷冻保存的用途，帮助人们更灵活地规划他们的家庭。

多胎妊娠的风险

某些 ART 手术可能导致多胎妊娠，从而使孕产妇和胎儿的健康面临风险。此外，早产和低出生体重是多胎妊娠导致母亲和胎儿健康风险增加的两种併发症。在现场，在不牺牲高成功率的情况下降低这些风险是一个持续的挑战。

COVID-19 的影响

辅助生殖技术市场受到了COVID-19大流行的影响。不孕症治疗的暂时下降可能是由于关闭措施和对非必要医疗程序的限制，该行业可能会遭受暂时的挫折。然而，随着卫生系统适应新常态，对 ART 服务的需求显着增加。这场流行病引起了人们对生殖健康重要性的关注，因为人们重新评估了他们的优先事项，也许更加关注计划生育。此外，虚拟咨询和远端医疗的改进为不孕症治疗提供了更方便、更平易近人的方法。

体外受精（IVF）产业预计将在预测期内成为最大的产业

体外受精（IVF）是辅助生殖技术中最大的市场占有率。体外受精（IVF）涉及在体外使卵子与精子受精，并将产生的胚胎植入子宫。由于其适应性和高成功率，该技术已变得非常流行，现在是单身人士和患有不孕不育的夫妇的选择。此外，透过体外受精治疗不孕症对于男性因素不孕症、输卵管疾病和不明原因不孕症特别成功。

预计生育诊所领域在预测期内复合年增长率最高

复合年增长率最高的细分市场是生育诊所。 IVF和IUI等辅助生殖技术以及其他不孕症治疗是生育诊所的重点。我们也提供生殖健康服务。此外，由于对这些专业服务的需求不断增加以及 ART 程序和技术的改进，生育诊所市场正在经历强劲增长。此外，生育诊所提供专门且专注的生殖医学方法，吸引寻求深入了解生育治疗的个人和夫妻。

占有率最大的地区：

欧洲地区预计将占据全球辅助生殖技术市场的最大占有率。英国、德国、法国、西班牙等欧洲国家医疗体系完善，不孕症治疗的接受度不断提高。大量的 ART 治疗得到该地区先进的法规结构、熟练的生殖专家和最先进的生育诊所网络的支持。此外，欧洲仍然是全球辅助生殖技术市场的主要参与企业，提供广泛的生殖服务并推动生殖健康领域的改善。

复合年增长率最高的地区：

在全球辅助生殖技术市场中，亚太地区预期复合年增长率最高。该地区（包括中国、印度和日本）对生殖保健的需求显着增加。亚太地区的高成长归因于多种因素，包括不孕率上升、辅助生殖技术的接受度提高以及医疗基础设施的进步。此外，政府奖励计画和公众对计划生育意识的改变也推动了亚太地区ART市场的快速扩张。

免费客製化服务

订阅此报告的客户可以利用以下免费自订选项之一：

  • 公司简介
    • 其他市场参与企业的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计/预测/复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究资讯来源
    • 主要研究资讯来源
    • 二次研究资讯来源
    • 先决条件

第三章市场趋势分析

  • 介绍
  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 技术分析
  • 最终用户分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球辅助生殖科技市场：依产品

  • 介绍
  • 装置
    • 精子分离系统
    • 冷冻系统
    • 孵化器
    • 影像系统
    • 抽卵子泵
    • 橱柜
    • 显微操作器
    • 雷射系统
  • 配件和一次性用品
  • 试剂和介质
    • 冷冻保存介质
    • 精液处理培养基
    • 卵子处理培养基
    • 胚胎培养液
  • 其他产品

第六章全球辅助生殖技术市场：依程序

  • 介绍
  • 新的捐赠者
  • 新鲜的非捐赠者
  • 冷冻供体
  • 冷冻非捐赠者
  • 胚胎/卵子库
  • 其他治疗

第七章全球辅助生殖科技市场：依科技分类

  • 介绍
  • 体外受精（IVF）
    • 显微授精和胞浆内单一精子注射 (ICSI)
    • 无 ICSI 的 IVF
  • 人工授精 - 子宫内授精 (AI-IUI)
  • 冷冻胚胎交换（FER）
  • 代理孕母
  • 诱导排卵
  • 其他技术

第八章全球辅助生殖技术市场：依最终用户分类

  • 介绍
  • 医院
  • 不孕不育治疗诊所
  • 手术中心
  • 临床研究所
  • 其他最终用户

第九章全球辅助生殖技术市场：按地区

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 中东和非洲其他地区

第10章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十一章 公司简介

  • Ferring BV
  • Apollo Hospitals Enterprise Ltd.
  • INVO Bioscience
  • Laboratoire CCD
  • Nidacon International AB
  • Fujifilm Holdings Corporation
  • Bloom Fertility Centre
  • Inception Sciences, Inc.
  • Thermo Fisher Scientific, Inc
  • Oxford Gene Technology Ip Ltd
  • Vitrolife AB
  • California Cryobank
  • Hamilton Thorne Inc.
  • Merck KGaA
  • CooperSurgical Inc.
  • OvaScience Inc.
Product Code: SMRC24544

According to Stratistics MRC, the Global Assisted Reproductive Technology (ART) Market is accounted for $29.01 billion in 2023 and is expected to reach $57.99 billion by 2030 growing at a CAGR of 10.4% during the forecast period. Assisted Reproductive Technology (ART) describes a variety of medical treatments intended to help individuals or couples become pregnant in cases where conventional methods are not successful. Intrauterine insemination (IUI), in vitro fertilization (IVF), and fertility drugs are all included under this general term. Moreover, reproductive medicine has changed dramatically as a result of ART, which gives hope to those who are infertile or have trouble getting pregnant.

According to the data published on female infertility in the National Library of Medicines in December 2022, globally, 11% of women who had a previous live birth were unable to have another, and 2% of women aged 20 to 44 were unable to have any live births at all.

Market Dynamics:

Driver:

Growing rates of infertility

Infertility rates are rising, and the causes are largely related to modern lifestyles characterized by high levels of stress, sedentary behavior, and environmental variables. Additionally, medical disorders like endometriosis and polycystic ovarian syndrome (PCOS) greatly raise the incidence of infertility. The need for assisted reproductive technology (ART) is growing as more people and couples struggle to conceive naturally, highlighting these interventions as essential remedies for fertility problems.

Restraint:

Restricted success rates

Even though success rates for ART procedures-particularly in vitro fertilization-have increased due to technological advancements, pregnancy is not a given with these procedures. Furthermore, the effectiveness of these interventions may be limited by individual differences in response to treatments as well as by age and underlying medical conditions. For those considering ART, the fact that there are inherent uncertainties and varying success rates continues to be a major deterrent.

Opportunity:

Increasing cryopreservation's uses

Reproductive materials, such as eggs, sperm, and embryos, can have their viability extended through cryopreservation techniques like vitrification. Moreover, better synchronization with people's life decisions and circumstances is made possible by this. With the ability to store fertility for later use, cryopreservation's growing applications help people plan their families with more flexibility.

Threat:

Multiple pregnancy risks

The health of the mother and fetus are at risk due to the possibility of multiple pregnancies that are linked to certain ART procedures. Furthermore, preterm birth and low birth weight are two complications that increase health risks for mothers and their unborn children when they result from multiple pregnancies. In the field, reducing these risks without sacrificing high success rates is an ongoing challenge.

COVID-19 Impact:

The market for assisted reproductive technologies (ART) has been impacted by the COVID-19 pandemic. One could argue that the industry suffered a temporary setback when lockdowns and restrictions on non-essential medical procedures caused a temporary decline in fertility treatments. Nevertheless, there has been a noticeable uptick in demand for ART services as healthcare systems have adjusted to the new normal. Due to people re-evaluating their priorities and perhaps becoming more interested in family planning, the pandemic brought attention to the significance of reproductive health. Furthermore, improvements in virtual consultations and telehealth emerged as a benefit, providing a more convenient and approachable method of fertility treatment.

The In Vitro-fertilization (IVF) segment is expected to be the largest during the forecast period

In vitro fertilization (IVF) is the market segment with the largest share within Assisted Reproductive Technologies (ART). During in vitro fertilization (IVF), an egg is fertilized with sperm outside of the body, and the resultant embryo is then inserted into the uterus. Due to its adaptability and high success rates, this technique has become very popular and is now the preferred choice for singles and couples dealing with infertility issues. Moreover, when it comes to male factor infertility, fallopian tube disorders, and infertility that remains unexplained, infertility treatment with IVF is especially successful.

The Fertility Clinics segment is expected to have the highest CAGR during the forecast period

The market segment with the highest CAGR is fertility clinics. Providers of assisted reproductive technologies (ART), such as IVF and IUI, as well as other fertility treatments, are the focus of fertility clinics. They also offer complete reproductive healthcare services. In addition, the fertility clinic market has experienced strong growth due to the rising demand for these specialized services as well as improvements in ART procedures and technology. Additionally, a committed and targeted approach to reproductive care is provided by fertility clinics, which attract individuals and couples looking for in-depth knowledge of infertility treatments.

Region with largest share:

The largest share of the market for assisted reproductive technology (ART) worldwide is predicted to go to the European region. Well-established healthcare systems and a growing acceptance of fertility treatments are features of European nations like the United Kingdom, Germany, France, and Spain. A vast array of ART procedures are supported by the region's progressive regulatory frameworks, skilled reproductive specialists, and network of cutting-edge fertility clinics. Furthermore, Europe is still a major player in the global ART market, offering a wide range of reproductive services and encouraging improvements in the field of reproductive medicine.

Region with highest CAGR:

In the global assisted reproductive technology (ART) market, the Asia-Pacific region is projected to have the highest CAGR. This region, which includes China, India, and Japan, has seen a notable increase in the demand for reproductive treatments. The high growth in Asia-Pacific is attributed to a number of factors, including rising rates of infertility, rising acceptance of assisted reproductive technologies, and advancements in healthcare infrastructure. Additionally, encouraging government programs and shifting public perceptions of family planning are factors driving the rapid expansion of the ART market in Asia-Pacific.

Key players in the market:

Some of the key players in Assisted Reproductive Technology (ART) market include Ferring B.V., Apollo Hospitals Enterprise Ltd., INVO Bioscience, Laboratoire CCD, Nidacon International AB, Fujifilm Holdings Corporation, Bloom Fertility Centre, Inception Sciences, Inc., Thermo Fisher Scientific, Inc, Oxford Gene Technology Ip Ltd, Vitrolife AB, California Cryobank, Hamilton Thorne Inc., Merck KGaA, CooperSurgical Inc. and OvaScience Inc.

Key Developments:

In November 2023, Apollo Hospitals Enterprise Limited will invest around Rs 3,435 crore over the next three years to add 2,300 beds in metros and major cities in different parts of the country. The leading healthcare chain is also looking at Operations and Management agreements overseas in Indonesia and Tanzania, though it will not be investing for the purpose.

In November 2023, Japanese conglomerate Fujifilm Holdings Corp and US pharma giant Bristol Myers Squibb Co have agreed to buy the entire output of a 270-MW solar project being developed by National Grid Renewables in Texas. Each of the two companies has sealed virtual power purchase agreements (PPAs) with the Minneapolis, Minnesota-based renewable energy developer, the latter said on Wednesday.

In October 2023, INVO Bioscience, Inc., a healthcare services company focused on expanding access to advanced fertility treatment worldwide, and NAYA Biosciences Inc., a company dedicated to increasing patient access to breakthrough treatments in oncology and regenerative medicine, today jointly announced that they have entered into a definitive merger agreement for INVO to acquire NAYA Biosciences in an all-stock transaction.

Products Covered:

  • Instrument
  • Accessory & Disposable
  • Reagents & Media
  • Other Products

Procedures Covered:

  • Fresh Donor
  • Fresh Nondonor
  • Frozen Donor
  • Frozen Nondonor
  • Embryo/Egg Banking
  • Other Procedures

Technologies Covered:

  • In Vitro-fertilization (IVF)
  • Artificial Insemination - Intrauterine Insemination (AI-IUI)
  • Frozen Embryo Replacement (FER)
  • Surrogacy
  • Ovulation Induction
  • Other Technologies

End Users Covered:

  • Hospital
  • Fertility Clinics
  • Surgical Center
  • Clinical Research Institutes
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Assisted Reproductive Technology (ART) Market, By Product

  • 5.1 Introduction
  • 5.2 Instrument
    • 5.2.1 Sperm Separation System
    • 5.2.2 Cryosystem
    • 5.2.3 Incubator
    • 5.2.4 Imaging System
    • 5.2.5 Ovum Aspiration Pump
    • 5.2.6 Cabinet
    • 5.2.7 Micromanipulator
    • 5.2.8 Laser Systems
  • 5.3 Accessory & Disposable
  • 5.4 Reagents & Media
    • 5.4.1 Cryopreservation Media
    • 5.4.2 Semen Processing Media
    • 5.4.3 Ovum Processing Media
    • 5.4.4 Embryo Culture Media
  • 5.5 Other Products

6 Global Assisted Reproductive Technology (ART) Market, By Procedure

  • 6.1 Introduction
  • 6.2 Fresh Donor
  • 6.3 Fresh Nondonor
  • 6.4 Frozen Donor
  • 6.5 Frozen Nondonor
  • 6.6 Embryo/Egg Banking
  • 6.7 Other Procedures

7 Global Assisted Reproductive Technology (ART) Market, By Technology

  • 7.1 Introduction
  • 7.2 In Vitro-fertilization (IVF)
    • 7.2.1 IVF with Intracytoplasmic Sperm Injection (ICSI)
    • 7.2.2 IVF without ICSI
  • 7.3 Artificial Insemination - Intrauterine Insemination (AI-IUI)
  • 7.4 Frozen Embryo Replacement (FER)
  • 7.5 Surrogacy
  • 7.6 Ovulation Induction
  • 7.7 Other Technologies

8 Global Assisted Reproductive Technology (ART) Market, By End User

  • 8.1 Introduction
  • 8.2 Hospital
  • 8.3 Fertility Clinics
  • 8.4 Surgical Center
  • 8.5 Clinical Research Institutes
  • 8.6 Other End Users

9 Global Assisted Reproductive Technology (ART) Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Ferring B.V.
  • 11.2 Apollo Hospitals Enterprise Ltd.
  • 11.3 INVO Bioscience
  • 11.4 Laboratoire CCD
  • 11.5 Nidacon International AB
  • 11.6 Fujifilm Holdings Corporation
  • 11.7 Bloom Fertility Centre
  • 11.8 Inception Sciences, Inc.
  • 11.9 Thermo Fisher Scientific, Inc
  • 11.10 Oxford Gene Technology Ip Ltd
  • 11.11 Vitrolife AB
  • 11.12 California Cryobank
  • 11.13 Hamilton Thorne Inc.
  • 11.14 Merck KGaA
  • 11.15 CooperSurgical Inc.
  • 11.16 OvaScience Inc.

List of Tables

  • Table 1 Global Assisted Reproductive Technology (ART) Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Assisted Reproductive Technology (ART) Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Assisted Reproductive Technology (ART) Market Outlook, By Instrument (2021-2030) ($MN)
  • Table 4 Global Assisted Reproductive Technology (ART) Market Outlook, By Sperm Separation System (2021-2030) ($MN)
  • Table 5 Global Assisted Reproductive Technology (ART) Market Outlook, By Cryosystem (2021-2030) ($MN)
  • Table 6 Global Assisted Reproductive Technology (ART) Market Outlook, By Incubator (2021-2030) ($MN)
  • Table 7 Global Assisted Reproductive Technology (ART) Market Outlook, By Imaging System (2021-2030) ($MN)
  • Table 8 Global Assisted Reproductive Technology (ART) Market Outlook, By Ovum Aspiration Pump (2021-2030) ($MN)
  • Table 9 Global Assisted Reproductive Technology (ART) Market Outlook, By Cabinet (2021-2030) ($MN)
  • Table 10 Global Assisted Reproductive Technology (ART) Market Outlook, By Micromanipulator (2021-2030) ($MN)
  • Table 11 Global Assisted Reproductive Technology (ART) Market Outlook, By Laser Systems (2021-2030) ($MN)
  • Table 12 Global Assisted Reproductive Technology (ART) Market Outlook, By Accessory & Disposable (2021-2030) ($MN)
  • Table 13 Global Assisted Reproductive Technology (ART) Market Outlook, By Reagents & Media (2021-2030) ($MN)
  • Table 14 Global Assisted Reproductive Technology (ART) Market Outlook, By Cryopreservation Media (2021-2030) ($MN)
  • Table 15 Global Assisted Reproductive Technology (ART) Market Outlook, By Semen Processing Media (2021-2030) ($MN)
  • Table 16 Global Assisted Reproductive Technology (ART) Market Outlook, By Ovum Processing Media (2021-2030) ($MN)
  • Table 17 Global Assisted Reproductive Technology (ART) Market Outlook, By Embryo Culture Media (2021-2030) ($MN)
  • Table 18 Global Assisted Reproductive Technology (ART) Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 19 Global Assisted Reproductive Technology (ART) Market Outlook, By Procedure (2021-2030) ($MN)
  • Table 20 Global Assisted Reproductive Technology (ART) Market Outlook, By Fresh Donor (2021-2030) ($MN)
  • Table 21 Global Assisted Reproductive Technology (ART) Market Outlook, By Fresh Nondonor (2021-2030) ($MN)
  • Table 22 Global Assisted Reproductive Technology (ART) Market Outlook, By Frozen Donor (2021-2030) ($MN)
  • Table 23 Global Assisted Reproductive Technology (ART) Market Outlook, By Frozen Nondonor (2021-2030) ($MN)
  • Table 24 Global Assisted Reproductive Technology (ART) Market Outlook, By Embryo/Egg Banking (2021-2030) ($MN)
  • Table 25 Global Assisted Reproductive Technology (ART) Market Outlook, By Other Procedures (2021-2030) ($MN)
  • Table 26 Global Assisted Reproductive Technology (ART) Market Outlook, By Technology (2021-2030) ($MN)
  • Table 27 Global Assisted Reproductive Technology (ART) Market Outlook, By In Vitro-fertilization (IVF) (2021-2030) ($MN)
  • Table 28 Global Assisted Reproductive Technology (ART) Market Outlook, By IVF with Intracytoplasmic Sperm Injection (ICSI) (2021-2030) ($MN)
  • Table 29 Global Assisted Reproductive Technology (ART) Market Outlook, By IVF without ICSI (2021-2030) ($MN)
  • Table 30 Global Assisted Reproductive Technology (ART) Market Outlook, By Artificial Insemination - Intrauterine Insemination (AI-IUI) (2021-2030) ($MN)
  • Table 31 Global Assisted Reproductive Technology (ART) Market Outlook, By Frozen Embryo Replacement (FER) (2021-2030) ($MN)
  • Table 32 Global Assisted Reproductive Technology (ART) Market Outlook, By Surrogacy (2021-2030) ($MN)
  • Table 33 Global Assisted Reproductive Technology (ART) Market Outlook, By Ovulation Induction (2021-2030) ($MN)
  • Table 34 Global Assisted Reproductive Technology (ART) Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 35 Global Assisted Reproductive Technology (ART) Market Outlook, By End User (2021-2030) ($MN)
  • Table 36 Global Assisted Reproductive Technology (ART) Market Outlook, By Hospital (2021-2030) ($MN)
  • Table 37 Global Assisted Reproductive Technology (ART) Market Outlook, By Fertility Clinics (2021-2030) ($MN)
  • Table 38 Global Assisted Reproductive Technology (ART) Market Outlook, By Surgical Center (2021-2030) ($MN)
  • Table 39 Global Assisted Reproductive Technology (ART) Market Outlook, By Clinical Research Institutes (2021-2030) ($MN)
  • Table 40 Global Assisted Reproductive Technology (ART) Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.